NGVT Stock Price, Quote & Chart | INGEVITY CORP (NYSE:NGVT)
This article provides a detailed overview of Ingevity Corp (NYSE: NGVT) stock, including its current price, performance metrics, technical and fundamental ratings from ChartMill, and analyst forecasts. It highlights the company's recent earnings, financial health, ownership structure, and its position within the Specialty Chemicals industry.
Wellington holds 1.49M Ingevity shares (NGVT) in 13G/A amendment
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G/A, reporting beneficial ownership of 1,494,292 shares of Ingevity Corporation (NGVT) common stock, which represents 4.24% of the class. The filing indicates shared voting power of 1,251,096 shares and shared dispositive power of 1,494,292 shares as of March 31, 2026. These shares are held of record by clients of Wellington investment advisers, and the amendment was signed on May 15, 2026.
Precision Trading with Ingevity Corporation (NGVT) Risk Zones
This article provides a precision trading analysis for Ingevity Corporation (NGVT), highlighting a weak near-term sentiment but long-term strength. It outlines institutional trading strategies based on AI models, including position, momentum breakout, and risk hedging strategies with specific entry, target, and stop-loss zones. The analysis also details multi-timeframe signal strength, support, and resistance levels for NGVT.
NCPD responding to structure fire at North Charleston Ingevity plant
The North Charleston Fire Department (NCFD) is responding to a structure fire at an Ingevity chemical plant. Officials have stated that the fire is isolated to a single column within the plant, which is used to process chemicals. This remains a developing story.
Ingevity reaffirms 2026 adjusted EPS of $4.70 to $5.20 while advancing APT sale process toward year-end
Ingevity Corporation reaffirmed its previously stated adjusted EPS guidance for 2026, projecting figures between $4.70 and $5.20. The company also announced that it is making progress on the sale of its Engineered Polymers business, also known as APT, and expects to finalize the process by the end of the year. This reiteration of financial targets and update on the divestiture indicate the company's strategic focus and confidence in its future performance.
Should Ingevity’s Divestiture-Driven Earnings and ESOP Shelf Filing Prompt Strategic Reassessment From NGVT Investors?
Ingevity Corporation recently reported Q1 2026 results, with net income significantly boosted by a US$55.6 million gain from the divestiture of its Industrial Specialties and Road Markings product lines. The company also filed an ESOP shelf registration for US$45.16 million, signaling a strategic shift towards higher-margin core businesses. This article examines how these actions impact Ingevity's investment profile, stressing the importance of evaluating both the benefits of portfolio simplification and ongoing exposure to cyclical industrial and automotive markets.
Ingevity clocks solid Q1 2026 results
Ingevity Corporation reported a solid first quarter for 2026, with net sales up 4% to $258.0 million due to pricing gains and favorable foreign exchange. Despite some segment challenges, the company maintained steady adjusted EBITDA and reaffirmed its full-year outlook, aiming for deleveraging and continued shareholder returns.
Top Ingevity (NGVT) Competitors 2026
This article analyzes Ingevity (NGVT) and its primary competitors: Avient (AVNT), Stepan (SCL), Timken (TKR), Element Solutions (ESI), and ICL Group (ICL). It compares these companies across various financial metrics, analyst ratings, profitability, institutional ownership, media sentiment, and market volatility to determine which might be a more favorable investment. Overall, Avient, Timken, and Element Solutions generally outperform Ingevity in a majority of the compared factors.
Assessing Ingevity (NGVT) Valuation After Strong Q1 2026 Earnings And Share Price Momentum
Ingevity (NGVT) has seen significant share price momentum following strong Q1 2026 earnings, reporting US$258 million in sales and US$59.8 million in net income. Despite being near its analyst price target and screening as undervalued by a discounted cash flow (DCF) model, its current P/S ratio appears rich compared to the industry and peers. The article suggests investors consider both the potential undervaluation based on DCF and the higher P/S multiple to assess valuation risk.
NGVT Reports Strong Q1 Revenue of $258M Reflecting Positive Tren
Ingevity Corp (NGVT) announced strong first-quarter revenue of $258 million, exceeding analyst expectations. The company's strategic divestiture of non-core divisions enabled $52 million in share repurchases and reinforced confidence in its full-year outlook. Despite a moderate GF Score™ of 68/100 and concerns regarding financial strength, Ingevity demonstrates efficiency in generating profits.
NGVT Sets 2025 Revenue Forecast Between $1.05B and $1.15B
Ingevity Corp (NGVT) has announced its 2025 revenue forecast to be between $1.05 billion and $1.15 billion, falling short of the consensus estimate of $1.19 billion. The company, operating in the specialty chemicals sector, has a GF Score™ of 68/100, indicating moderate financial health but with concerns regarding its growth and financial strength. Investors are advised to proceed with caution due to the lower guidance and lack of recent insider trading activity.
Ingevity reaffirms 2026 adjusted EPS of $4.70 to $5.20 while advancing APT sale process toward year-end
Ingevity Corporation has reaffirmed its adjusted EPS guidance for 2026, targeting a range of $4.70 to $5.20, and announced progress on the potential sale of its Advanced Polymer Technologies (APT) business, aiming for completion by year-end. This announcement was made during the company's investor day, where it also detailed its strategic outlook and financial targets.
Earnings call transcript: Ingevity Q1 2026 EPS beats but revenue misses
Ingevity Corporation reported Q1 2026 earnings with an EPS of $1.15, significantly beating analyst expectations, but revenues of $258 million missed forecasts by 7.53%. Despite the strong EPS, the stock fell 4.57% due to investor concerns about the revenue shortfall. The company's strategic divestitures and focus on core businesses like Performance Materials, benefiting from the shift to hybrid vehicles, are key to its strategy.
Ingevity Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:NGVT) 2026-05-07
Ingevity Corporation (NGVT) reported its Q1 2026 earnings, with EPS of $1.15, beating estimates by $0.32, and revenue of $258.00M, beating expectations by $3.27M despite a 9.15% year-over-year decrease. The company released a slide deck for its earnings call on May 7, 2026.
Ingevity: Q1 Earnings Snapshot
Ingevity Corporation (NGVT) reported a first-quarter profit of $59.8 million, or $1.66 per share, with adjusted earnings of $1.15 per share. The company posted $258 million in revenue for the period. Ingevity anticipates full-year earnings between $4.70 and $5.20 per share and revenue ranging from $1.05 billion to $1.15 billion.
Earnings Flash (NGVT) Ingevity Corporation Reports Q1 Revenue $258.0M, vs. FactSet Est of $254.7M
Ingevity Corporation announced its Q1 revenue reached $258.0 million, surpassing FactSet's estimate of $254.7 million. The company, which specializes in diversified chemicals including performance materials, advanced polymer technologies, and performance chemicals, reported these results on May 6, 2026. This financial update indicates a better-than-expected performance for the first quarter.
Earnings Flash (NGVT) Ingevity Corporation Posts Q1 Adjusted EPS $1.15 per Share, vs. FactSet Est of $0.83
Ingevity Corporation (NGVT) reported a Q1 adjusted EPS of $1.15 per share, surpassing the FactSet estimate of $0.83. The company operates in Performance Materials, Advanced Polymer Technologies, and Performance Chemicals segments, providing solutions across various industries. This positive earnings surprise comes after several recent company activities, including the sale of its Ozark Materials Road Markings business and amendments to its credit agreement.
Ingevity: Q1 Earnings Snapshot
Ingevity Corporation (NGVT) reported a first-quarter profit of $59.8 million, or $1.66 per share, with adjusted earnings of $1.15 per share. The company's revenue for the period was $258 million. Ingevity anticipates full-year earnings to be between $4.70 and $5.20 per share, with revenue ranging from $1.05 billion to $1.15 billion.
Ingevity earnings up next: Margin gains in focus after divestitures
Ingevity Corp. is set to report its first-quarter earnings, with investors focusing on the company's margin gains and cash generation following its recent portfolio transformation. Analysts expect 83 cents per share on $279 million in revenue, a sequential improvement from the previous quarter. The company has recently divested its Industrial Specialties and Ozark Materials units and aims to generate about $1 billion in deployable cash over the next two years.
How Ingevity’s Expanded Incentive Plan And Buybacks At Ingevity (NGVT) Have Changed Its Investment Story
Ingevity shareholders approved an expanded Omnibus Incentive Plan and share repurchases, with management projecting over US$270 million in 2025 free cash flow. These initiatives, including director equity grants, aim to align board compensation with long-term share performance and reinforce governance, though near-term earnings volatility and APT segment weakness remain factors. The article discusses how these changes interact with Ingevity's investment narrative, emphasizing the importance of cash generation and divestitures amidst a high debt load and potential APT margin pressure.
Ingevity (NGVT) SVP receives 1,262 RSUs, now holds 31,633 shares
Ingevity's SVP of Finance and Chief Accounting Officer, Phillip John Platt, was granted 1,262 restricted stock units (RSUs) on May 1, 2026, under the company's 2025 Omnibus Incentive Plan. These RSUs will vest in three equal installments from 2027 to 2029. Following this grant, Platt directly holds a total of 31,633 Ingevity common shares, which includes 422 shares acquired through an Employee Stock Purchase Plan.
Ingevity Q1 2026 Earnings Preview — May 7, Street Expects $0.83 EPS
Ingevity Corporation is scheduled to report its first-quarter 2026 earnings on May 7, with analysts forecasting an EPS of $0.83 on revenue of $254.7 million. Analyst expectations for EPS have been declining over recent months, signaling concerns about near-term business conditions. The company is expected to see a year-over-year contraction in both earnings and revenue, with profitability likely under pressure.
Ingevity Shareholders Back Directors and Expanded Incentive Plan
Ingevity Corporation shareholders re-elected nine directors, approved executive compensation, and ratified PricewaterhouseCoopers LLP as their independent auditor during their annual meeting on April 29, 2026. They also approved an amendment to the 2025 Omnibus Incentive Plan, adding 580,000 shares for future equity-based compensation, indicating strong support for the company's governance and long-term incentives. Spark, TipRanks' AI Analyst, rates NGVT as Neutral due to financial weakness despite positive technical momentum and outlook on profitability and cash flow.
Ingevity (NGVT) investors approve 580,000-share increase to 2025 incentive plan
Ingevity Corporation stockholders approved an amendment to the 2025 Omnibus Incentive Plan, increasing the number of shares available for issuance by 580,000. This decision was made at their annual meeting on April 29, 2026, where all nine director nominees were also elected for one-year terms. Additionally, shareholders approved executive officer compensation on an advisory basis and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2026.
NGVT SEC Filings - Ingevity Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Ingevity Corporation (NYSE: NGVT) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, and 8-K material event reports, with AI-powered context and summaries. It details recent filings such as a director's increase in stake and the departure of the Performance Materials Chief, outlining financial implications and strategic shifts. Investors can track Ingevity’s business segments (Performance Materials, Advanced Polymer Technologies, Performance Chemicals) and how its portfolio is managed and restructured.
Director at Ingevity (NYSE: NGVT) granted 1,904 RSUs
Frederick J. Lynch, a director at Ingevity (NYSE: NGVT), was granted 1,904 restricted stock units (RSUs) of Ingevity common stock at no purchase price. This award was part of the company’s 2025 Omnibus Incentive Plan and will vest in full on April 30, 2027. Following this grant, Lynch's direct holdings in Ingevity total 28,263 shares.
Ingevity (NGVT) director awarded 1,904 restricted stock units as equity pay
Ingevity Corp (NGVT) director Luis M. Fernandez-Moreno was granted 1,904 restricted stock units on April 30, 2026, as an equity award under the company's 2025 Omnibus Incentive Plan. These units, which have no cash exercise price, will vest in full on April 30, 2027. Following this transaction, Fernandez-Moreno directly holds 37,882 shares of Ingevity common stock.
Director Diane Gulyas (NGVT) receives 1,904 Ingevity restricted stock units
Ingevity director Diane Gulyas was granted 1,904 restricted stock units (RSUs) under the company's 2025 Omnibus Incentive Plan. These RSUs have a grant price of $0.00 and will fully vest on April 30, 2027. Following this transaction, Gulyas directly holds 14,788 shares of Ingevity common stock and indirectly holds an additional 3,747 shares through the Diane H. Gulyas Trust.
Ingevity (NGVT) director Narwold receives 1,904-share restricted stock grant
Ingevity Corp director Karen G. Narwold received a grant of 1,904 restricted stock units under the company's 2025 Omnibus Incentive Plan. These shares, valued at $0.00 per share, are compensation-related and will vest in full on April 30, 2027, increasing her direct holdings to 18,900 shares. This transaction is a routine equity-based compensation award, not an open-market purchase.
Ingevity (NGVT) director awarded 1,904 RSUs vesting in 2027
Ingevity Corp director Francis David Segal was granted 1,904 restricted stock units (RSUs) under the company's 2025 Omnibus Incentive Plan. These RSUs, awarded at no cost, will vest in full on April 30, 2027. Following this grant, Segal directly holds 8,284 shares of Ingevity common stock.
Revenue per share of Ingevity Corporation – MUN:IGX
This article focuses on the revenue per share of Ingevity Corporation (MUN:IGX), a company listed on the Munich Stock Exchange under the Chemicals: Major Diversified sector. It provides a snapshot of the company's financial data, specifically highlighting its revenue per share over various periods. The page also outlines data sources from ICE Data Services and FactSet for market and reference information.
Pictet Asset Management Holding SA Has $21.26 Million Stake in Ingevity Corporation $NGVT
Pictet Asset Management Holding SA reduced its stake in Ingevity Corporation by 4.6% in the fourth quarter, now holding 359,210 shares valued at $21.26 million, representing 1.00% of the company. Ingevity recently missed Q4 earnings estimates with $0.58 EPS against an expected $0.74, and reported revenue of $255.1 million versus $257.3 million. Despite a consensus "Hold" rating and an average price target of $80 from Wall Street analysts, the stock trades near its 52-week high with a market cap of approximately $2.69 billion.
[SCHEDULE 13G] Ingevity Corp Passive Investment Disclosure (>5%)
Vanguard Capital Management has filed a Schedule 13G for Ingevity Corp (NGVT), disclosing a passive investment of 1,853,415 shares of Common Stock, which represents 5.26% of the class as of March 31, 2026. The filing indicates Vanguard has sole dispositive power over all these shares but sole voting power over only 271,544 shares. This disclosure, signed on April 30, 2026, by Ashley Grim, specifies that the investment is held in the ordinary course of business and not for changing or influencing company control.
Ingevity (NGVT) to Release Quarterly Earnings on Wednesday
Ingevity (NGVT) is scheduled to release its first-quarter 2026 earnings after the market closes on Wednesday, May 6th. Analysts anticipate earnings per share of $0.84 and revenue of $254.73 million, with the company having set full-year 2026 EPS guidance between $4.80 and $5.20. The stock is currently trading around $74.77, and analysts have mixed ratings, suggesting a consensus target price of $80.00.
Vanguard Portfolio Management holds 6.27% of Ingevity (NGVT)
Vanguard Portfolio Management has reported a 6.27% ownership stake in Ingevity Corp (NGVT), equating to 2,209,879 shares. This filing, a Schedule 13G, indicates a passive investment primarily for Vanguard funds and managed client accounts. The filing highlights Vanguard's sole dispositive power over all shares and sole voting power over 33,148 shares.
Assessing Ingevity (NGVT) Valuation After Recent Share Price Momentum And Portfolio Repositioning
Ingevity (NGVT) has seen significant share price momentum recently, with a 1-year total shareholder return of 126.28%, contrasting with a longer-term decline. While the most popular narrative values NGVT at $80.50, suggesting it is undervalued, its current P/S ratio of 2.3x is richer than the industry average, indicating fewer opportunities for error. The company's portfolio repositioning and divestiture of non-core businesses are expected to drive margin improvement and focus on higher-growth specialty chemicals.
Ingevity stock hits 52-week high at 77.61 USD By Investing.com
Ingevity Corporation's stock has reached a 52-week high of $77.61, marking a significant 132.69% increase over the past year. This surge is attributed to strategic initiatives and positive market conditions, despite mixed Q4 2025 earnings where revenue exceeded forecasts but EPS fell short. Analysts from BMO Capital and Jefferies have raised price targets, maintaining positive ratings for the company.
Ingevity (NGVT) price target increased by 12.01% to 80.84
The article states that Ingevity (NGVT) has had its price target increased by 12.01%, bringing it to $80.84. This indicates a positive outlook on the company's stock from analysts.
Ingevity (NGVT) price target increased by 12.01% to 80.84
This article reports that the price target for Ingevity (NGVT) has been increased. The new target is $80.84, representing a 12.01% increase.
Ingevity sells Ozark Materials business to PPG
Ingevity Corp. has successfully sold its Ozark Materials road markings business to PPG in an all-cash transaction valued at approximately $65 million. This divestiture is part of Ingevity's strategy to sharpen its portfolio and focus on core growth areas, while Ozark Materials is expected to thrive under PPG's ownership due to their expertise in pavement marking solutions. Ingevity will continue to operate its Pavement Technologies business independently.
Ingevity Corp - All-Cash Deal Results in Proc
This article briefly reports on Ingevity Corp's all-cash deal. It mentions the result of this deal. The provided content is extremely brief and lacks detail.
NGVT sells Ozark Materials to PPG to streamline core operations
The article reports that the company NGVT has sold its subsidiary, Ozark Materials, to PPG. This divestiture is part of NGVT's strategy to streamline its core operations.
PPG acquires pavement markings manufacturer
PPG has acquired Ozark Materials, LLC, a U.S.-based provider of pavement marking solutions, from Ingevity Corporation for $65 million. This acquisition is expected to strengthen PPG's business by enhancing its ability to serve customers throughout North America and aligns with PPG's long-term strategy to expand its pavement marking business. Ozark Materials has approximately 130 employees and established customer relationships that complement PPG's Traffic Solutions business.
Ingevity Corporation (NYSE:NGVT) Receives Consensus Rating of "Hold" from Brokerages
Ingevity Corporation (NYSE:NGVT) has received a consensus "Hold" rating from five brokerages, with an average 12-month target price of $80.00. The company recently missed its quarterly earnings and revenue estimates, reporting $0.58 EPS against an expected $0.74, and $255.1 million in revenue against an expected $257.3 million. However, Ingevity set its FY2026 EPS guidance at $4.80-$5.20, which is above the street's average forecast of $4.45.
NGVT sells Ozark Materials to PPG to streamline core operations
NGVT has sold its Ozark Materials subsidiary to PPG. This strategic divestiture is aimed at allowing NGVT to streamline its core operations and focus on its primary business areas. The acquisition by PPG strengthens their portfolio.
Ingevity sells road markings unit to PPG for $65 million
Ingevity Corporation sold its Ozark Materials road markings business to PPG for approximately $65 million in cash, a move intended to sharpen Ingevity's portfolio and focus on core capabilities. Despite missing Q4 2025 EPS estimates, Ingevity affirmed its full-year guidance excluding the transaction's effects and saw its shares trade near a 52-week high after a 141% return over the past year. Analysts like Jefferies and BMO Capital have raised their price targets on Ingevity, citing positive demand outlooks and strong growth projections.
Ingevity sells road markings unit to PPG for $65 million By Investing.com
Ingevity Corporation has sold its Ozark Materials road markings business to PPG for approximately $65 million in cash, aiming to focus on core capabilities. The transaction has been positively received by investors, with Ingevity's shares trading near their 52-week high after a 141% return over the past year. Ingevity plans to update its full-year 2026 guidance to reflect the transaction's impact, while PPG, with $15.9 billion in net sales in 2025, continues to expand its operations globally.
Ingevity announces sale of Ozark Materials road markings business to PPG, strengthening strategic focus
Ingevity Corporation has sold its Ozark Materials road markings business to PPG for approximately $65 million in an all-cash transaction. This divestiture aligns with Ingevity's strategy to focus on its core businesses and does not impact its Pavement Technologies business. Ingevity plans to update its full-year 2026 guidance to reflect the impact of this sale.
Ingevity announces sale of Ozark Materials road markings business to PPG, strengthening strategic focus
Ingevity Corporation has announced the sale of its Ozark Materials road markings business to PPG for approximately $65 million, an all-cash transaction that has already closed. This divestiture allows Ingevity to sharpen its strategic focus on its core businesses, while PPG will integrate Ozark Materials into its existing pavement markings solutions. Ingevity plans to update its full-year 2026 financial guidance in conjunction with its first-quarter results to reflect the impact of this transaction.
Ingevity sells road markings unit to PPG for $65 million By Investing.com
Ingevity Corporation has sold its Ozark Materials road markings business to PPG for approximately $65 million in cash, aligning with Ingevity's strategy to focus on its core capabilities while remaining committed to its Pavement Technologies business. This divestiture has been positively received by investors, with Ingevity's shares trading near their 52-week high after a 141% return over the past year. Ingevity plans to update its 2026 financial guidance following this transaction.
